POLAR CAPITAL HOLDINGS PLC Revance Therapeutics, Inc. Transaction History

POLAR CAPITAL HOLDINGS PLC portfolio value:

$120.46M
portfolio value

POLAR CAPITAL HOLDINGS PLC quarter portfolio value change:

+95.37%
quarter

Revance Therapeutics, Inc. 13F transactions

Quarter Transaction type Change Relative change Absolute change Change value Avg. price Shares
Q3 2022 share Increase +43.14% 1.34M shares 77.38M $27 4.46M
Q2 2022 share Increase +26.89% 660.55K shares -4.82M $13.82 3.11M
Q1 2022 share Increase +8.71% 196.79K shares 11.02M $19.5 2.45M
Q4 2021 share Increase +29.64% 516.70K shares -11.68M $16.49 2.25M
Q3 2021 share Increase +50.94% 588.26K shares 14.33M $27.86 1.74M
Q2 2021 share 0.00% 0 shares 1.95M $29.64 1.15M
Q1 2021 share 0.00% 0 shares -450K $27.95 1.15M
Q4 2020 share Increase 0.00% 1.15M shares 32.72M $28.34 1.15M